CPHI India 2026 is one of the major pharmaceutical industry exhibitions in India, providing a professional platform for pharmaceutical manufacturers, ingredient suppliers, formulation companies, distributors, researchers, procurement professionals, investors and other stakeholders involved in the pharmaceutical supply chain. The 2026 edition of CPHI India is scheduled to take place from 23 to 25 November 2026 at IICC, Yashobhoomi, Dwarka, New Delhi. An important change for 2026 is that CPHI India and PMEC India will operate at two separate venues while remaining part of the same overall pharmaceutical industry event. PMEC India will take place from 24 to 26 November 2026 at the India Expo Mart Limited (IEML) in Greater Noida.

The new two-venue format has been introduced to provide more space and a more focused experience for exhibitors and visitors. CPHI India at Yashobhoomi will concentrate primarily on pharmaceutical ingredients, chemicals and finished pharmaceutical products, while PMEC India in Greater Noida will focus on pharmaceutical manufacturing machinery, processing technologies, packaging, laboratory equipment and cleanroom solutions. According to the organizers, the growing scale of the event created a need for additional space and better segmentation so that professionals can more efficiently connect with businesses relevant to their particular areas of interest.

CPHI India 2026 will cover several important segments of the pharmaceutical supply chain. Major areas at the event include active pharmaceutical ingredients, commonly known as APIs, finished dosage formulations, pharmaceutical excipients, natural extracts, fine chemicals and intermediates. These categories make the exhibition particularly relevant to pharmaceutical manufacturers looking for ingredients and materials required for drug development and commercial production. It also provides ingredient manufacturers and suppliers with an opportunity to introduce their capabilities to pharmaceutical companies seeking reliable sourcing partners.

The exhibition is expected to serve as an important business networking environment because pharmaceutical manufacturing depends on a highly interconnected international supply chain. Companies frequently need to establish relationships with API manufacturers, excipient suppliers, contract manufacturing organizations, formulation specialists, technology providers and other partners. CPHI India brings these different areas of the industry together, helping participating companies establish contacts, discuss requirements, identify potential suppliers and explore new commercial partnerships. The broader CPHI network operates pharmaceutical events internationally and describes its role as connecting companies and professionals across the global pharma community.

For pharmaceutical ingredient suppliers, CPHI India 2026 provides an opportunity to showcase products and manufacturing capabilities to professionals involved in purchasing, sourcing, formulation development and pharmaceutical production. Companies can use the exhibition to introduce APIs, excipients, intermediates, natural extracts and other materials while discussing specifications and potential supply arrangements directly with prospective customers. Pharmaceutical manufacturers visiting the event can, in turn, use the exhibition to discover new suppliers and investigate sourcing alternatives for their development and production requirements.

CPHI India 2026 is also expected to provide opportunities for knowledge sharing and discussions about developments affecting the pharmaceutical sector. The organizers have identified a wide range of themes for the 2026 programme, including policy and regulatory developments, global pharmaceutical market trends, market diversification, manufacturing and outsourcing, emerging and disruptive technologies, packaging and drug delivery, sustainable packaging, pharmaceutical ingredients and formulation, supply-chain dynamics, biomanufacturing, sustainability, innovation, strategy, biopharma, cell and gene therapy strategies, investment and partnerships.

The international nature of the CPHI platform is another important aspect of the event. Pharmaceutical companies increasingly operate across multiple markets, making international sourcing, regulatory compliance and supply-chain partnerships essential parts of the industry. CPHI’s worldwide event portfolio spans several continents and includes pharmaceutical exhibitions in Europe, Asia, the Americas and the Middle East. CPHI reports that its global event portfolio collectively attracts more than 323,000 attendees and over 12,700 exhibitors annually. These figures refer to the wider CPHI portfolio rather than CPHI India alone, but they demonstrate the international scale of the network to which the India exhibition belongs.

Another significant feature of the 2026 edition is the connection between CPHI India and PMEC India. While CPHI India concentrates on ingredients, chemicals and pharmaceutical products, PMEC India focuses on the equipment and technologies used to manufacture them. PMEC India will feature pharmaceutical machinery and equipment, packaging technologies, laboratory and analytical equipment, cleanroom technology, processing solutions and automation. Visitors interested in both pharmaceutical sourcing and manufacturing technology can therefore attend the two complementary exhibitions during the same trip.

The organizers have planned overlapping dates to make this dual-event structure more practical. CPHI India runs from 23 to 25 November, while PMEC India runs from 24 to 26 November, creating an overlap on 24 and 25 November. Regular shuttle services are planned between Yashobhoomi in Dwarka and IEML in Greater Noida during the overlapping period. The organizers also state that the same attendee badge will provide access to both events, allowing registered participants to explore both the pharmaceutical ingredients and manufacturing technology sides of the exhibition.

The choice of IICC, Yashobhoomi, as the CPHI India venue is intended to support the event’s expanding scale while providing modern exhibition and convention infrastructure. The venue is located in Dwarka, New Delhi, with access through road and metro networks and proximity to Delhi’s international airport. Meanwhile, IEML in Greater Noida has been retained for PMEC India because its exhibition facilities are suited to the larger physical requirements of heavy pharmaceutical machinery and industrial equipment displays.

CPHI India 2026 can be particularly relevant for professionals working in pharmaceutical manufacturing, sourcing, procurement, formulation development, research and development, business development, international trade, distribution and supply-chain management. Companies seeking new APIs, excipients or intermediates can meet potential suppliers, while ingredient manufacturers can establish contacts with pharmaceutical producers and buyers. International companies can use the event to understand opportunities within India’s pharmaceutical market, while Indian businesses can connect with overseas partners and explore potential export relationships.

The event also reflects wider developments within pharmaceutical manufacturing, where supply-chain resilience, regulatory requirements, sustainability, advanced manufacturing technologies and international partnerships are increasingly important. Discussions and business meetings at the exhibition can help participants understand how companies are responding to these developments and what new products, technologies and commercial opportunities are emerging across the sector.

CPHI India 2026 therefore represents much more than a conventional pharmaceutical product exhibition. It brings together different parts of the pharmaceutical value chain within a business-oriented environment designed for sourcing, networking, market development and industry knowledge exchange. The introduction of separate but connected CPHI India and PMEC India venues in 2026 creates a more specialized structure, with ingredients and pharmaceutical products presented at Yashobhoomi and manufacturing machinery and technologies showcased in Greater Noida. For pharmaceutical companies, suppliers, manufacturers and industry professionals seeking business opportunities in India and international markets, the event provides a concentrated opportunity to meet potential partners and explore developments shaping the pharmaceutical industry.

Official event details, visitor information and registration are available through the CPHI & PMEC India official website.